Polymorphism Tth111I of the NR3C1 gene differentiates asthma patients according to the symptom control level based on the ACTTM test score into two subpopulations (ACTTM score <20 vs. ACTTM score ≥20). This evidence concerns the gene NR3C1 and asthma.